Specialized CRO partnership supports Phase 2 program to advance Nu-3 toward potential registration pathway in large, underserved iDFU market SARASOTA, Fla., May 12 ...

Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from ...

In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA, 3,588 patients initiated treatment, and ~5,400 prescriptions were filled Agreement signed in May with leading grou ...

Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of ...

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451Continued ...

Company to continue development of efzofitimod in pulmonary sarcoidosis incorporating FDA feedback. Company plans to submit ...

From Genryo’s Sidewinder technology to the Festival of Genomics & Biodata in the UK earlier this year – AI might be trending, ...

New research suggests a simple urine test could help spot conditions including bipolar disorder, ADHD and anorexia much ...

Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication ...

Scientists at the University of East Anglia (UK) have contributed to discovering a "control switch" inside our immune cells ...

Researchers Launch BHARAT Study: India’s First Large-Scale Search for Aging Biomarkers India is launching one of its most ...